Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping Categories

  1. 1. Mobile Phones
  2. 2. Digital Cameras
  3. 3. Smartphones
  4. 4. Laptop Computers
  5. 5. Graphics Cards
  6. 6. LCD TVs
  7. 7. LCD Monitors
  8. 8. Fridges
  9. 9. Vacuum Cleaners
  10. 10. Freezers
  11. 11. Washing Machines
  12. 12. Microwaves
  13. 13. Electric Kettles
  14. 14. Dishwashers
  15. 15. Digital Camcorders

Wikio Shopping

  1. 1. Baby & Nursery
  2. 2. Books
  3. 3. Car/Motorbike
  4. 4. CD
  5. 5. Communication
  6. 6. Computers
  7. 7. DVD
  8. 8. Electronics
  9. 9. Entertainment
  10. 10. Fashion & Lingerie
  11. 11. Finance
  12. 12. Gifts & Gadgets
  13. 13. Health & Beauty
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Sport & Fitness
  18. 18. Travel
  19. 19. Video Games

Participate



Alcon, Inc.



Sort by : relevance - date
3Vote!

Alcon 3Q profit down 18 percent without tax gain

Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit.

+Vote!

Alcon 3Q profit down 18 percent without tax gain

NEW YORK -- Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit.

3Vote!

Alcon Posts 5.9 Percent Sales Growth for Third Quarter

HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE:ACL) reported global sales rose 5.9 percent to $1,614 million for the third quarter of 2009, or a 9.0 percent increase excluding the impact of foreign exchange fluctuations. Net earnings for the third quarter of 2009 were $515 million, or $1.71 per diluted share. Excluding the impact of a $240 million tax benefit related to the...

Click here to see all comments

MAXIDEX DEXAMETHAONE WARNING

I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...

anonymous - 30/10/2009

3Vote!

Alcon 3Q profit down 18 percent without tax gain

Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit. Alcon's profit slipped to $515 million, or $1.71 per share, from $627 million, or $2.07 per share, in the... Sponsored Topics: Tax - Taxation - United States - Accounting - Society and Culture

+Vote!

Earnings roundup: CommVault, Alcon

Last updated October 28, 2009 3:30 p.m. PTEarnings roundup: CommVault, AlconTHE ASSOCIATED PRESSAmong the earnings stories for Wednesday, Oct. 28, from AP Financial News:OCEANPORT, N.J. -- CommVault Systems Inc. reported a flat fiscal second-quarter profit as rising operating expenses and revenue costs overshadowed an increase in sales.NEW YORK -- Eye drug maker Alcon Inc....

Click here to see all comments

MAXIDEX DEXAMETHASONE WRNING

I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...

anonymous - 30/10/2009

3Vote!

Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon

LOUISVILLE, Ky., Oct. 23 /PRNewswire/ -- Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered into licensing and purchase option agreements with Alcon Research, Ltd., a wholly-owned subsidiary of Alcon, Inc. (NYSE: ACL). The agreements provide Alcon...

Click here to see all comments

MAXIDEX DEXAMETHASONE WARNING

I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...

anonymous - 27/10/2009

3Vote!

Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon

Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with AlconPosted on: Friday, 23 October 2009, 07:00 CDT LOUISVILLE, Ky., Oct. 23 /PRNewswire/ -- Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered into licensing and purchase option agreements...

Click here to see all comments

MAXIDEX DEXAMETHASONE WARNING

I had eye surgery and in the post-op pack was MAXIDEX (dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...

anonymous - 27/10/2009

3Vote!

Alcon Announces Third Quarter 2009 Financial Release and Conference Call Dates

HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE: ACL) will report on its third quarter financial results for the period ended September 30, 2009 after the market close on Tuesday, October 27, 2009. Management of the company will host a conference call to discuss these results on Wednesday, October 28, 2009, at 8:30 a.m. Eastern Time. Presenting from Alcon will be Kevin...

3Vote!

ORBIS: ORBIS and Alcon Launch Pediatric Eye Care Program in India, and Gear Up for World Sight Day in Bangladesh

NEW YORK, NY (MARKET WIRE) Did you know that India accounts for nearly 20 percent of all blind children worldwide? ORBIS International's flagship Flying Eye Hospital arrived in Jaipur, India with its international team of volunteer eye care specialists and global sponsor Alcon, Inc. (NYSE: ACL), the world's leading eye care company. Invited by the Ministry of Health Services, hosted by...

Click here to see all comments

MAXIDEX DEXAMETHASONE WARNING

I had eye surgery and in the post-op pack was MAXIDEX (dexamethasone) drops by ALCON LABS. Two says later I was BLIND Use Google and enter EPOCRATES...

anonymous - 05/10/2009

3Vote!

ORBIS : ORBIS and Alcon Launch Pediatric Eye Care Program in India, While Gearing Up for World Sight Day in Bangladesh

NEW YORK, NY (MARKET WIRE) ORBIS International's flagship Flying Eye Hospital arrived in Jaipur, India with its international team of volunteer eye care specialists and global sponsor Alcon, Inc. (NYSE: ACL), the world's leading eye care company. Invited by the Ministry of Health Services, hosted by the Sahai Eye Hospital and Research Centre, S.M.S Medical College and generously sponsored...

+Vote!

Options Intelligence Report : Options Activity Analysis For ACL, VIX, FEED, ODP, NRG, NVTL, LVS & MSTR

Today's tickers: ACL, VIX, FEED, ODP, NRG, NVTL, LVS & MSTR [More...]

3Vote!

NovaBay to Hold Conference Call to Review Aganocide Data Presented at the Infectious Diseases Society of America Meeting

EMERYVILLE, Calif., Oct. 28 -- NovaBay Pharmaceuticals, Inc. (NYSE-Amex: NBY) will hold a webcast conference call on October 30, 2009 to review preclinical data from a study of Aganocide® product candidates NVC-422 and NVC-612 in a model of onychomycosis, com...

3Vote!

Novartis Raises Sales Forecast

Novartis raised its full-year sales outlook, although it reported flat third-quarter net profit as higher revenue was offset by charges related to its holdings in Alcon and Roche and as growth slowed in its profitable best-sellers.

Click here to see all comments

MAXIDEX DEXAMETHASONE wArnINg

I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...

anonymous - 22/10/2009

4Vote!

Galleon Group's 50 Largest Holdings

... almost certainly wind down, perhaps there are some good short opportunities. Name Ticker 1 EBAY INC EBAY 2 GOOGLE INC GOOG 3 APPLE INC AAPL 4 OSI PHARMACEUTICALS... OSIP 5 BANK OF AMERICA COR... BAC 6 JP MORGAN CHASE & CO JPM 7 CISCO SYS INC CSCO 8 SPDR S&P 500 SPY 9 DELL INC DELL 10 NVIDIA CORP NVDA 11 E M C CORP MASS EMC 12 WYETH WYE 13 PEPSI BOTTLING GROU... PBG 14 MEMC ELECTR MATLS...

3Vote!

Research Update: Ugrade of Nestle Implies No Cadbury Bid

... billion) share repurchase program. Erskine also expects Nestle will probably sell its stake in Alcon Inc. (ACL) “sooner rather than later,” potentially generating net cash of 8 billion Swiss francs by early 2010. Nestle has a put option to sell its 52 percent Alcon stake to Novartis AG (NOVN) between January 2010 and July 2011. For previous ResearchRecap posts on Cadbury ahead...